| molecular function |
|---|
| | GO:0042169 | | SH2 domain binding | | Interacting selectively and non-covalently with a SH2 domain (Src homology 2) of a protein, a protein domain of about 100 amino-acid residues and belonging to the alpha + beta domain class. |
| | GO:0017124 | | SH3 domain binding | | Interacting selectively and non-covalently with a SH3 domain (Src homology 3) of a protein, small protein modules containing approximately 50 amino acid residues found in a great variety of intracellular or membrane-associated proteins. |
| | GO:0016787 | | hydrolase activity | | Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3. |
| | GO:0016791 | | phosphatase activity | | Catalysis of the hydrolysis of phosphoric monoesters, releasing inorganic phosphate. |
| | GO:0004721 | | phosphoprotein phosphatase activity | | Catalysis of the reaction: a phosphoprotein + H2O = a protein + phosphate. Together with protein kinases, these enzymes control the state of phosphorylation of cell proteins and thereby provide an important mechanism for regulating cellular activity. |
| | GO:0001784 | | phosphotyrosine residue binding | | Interacting selectively and non-covalently with a phosphorylated tyrosine residue within a protein. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0019901 | | protein kinase binding | | Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate. |
| | GO:0004725 | | protein tyrosine phosphatase activity | | Catalysis of the reaction: protein tyrosine phosphate + H2O = protein tyrosine + phosphate. |
| | GO:0005001 | | transmembrane receptor protein tyrosine phosphatase activity | | Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: protein tyrosine phosphate + H2O = protein tyrosine + phosphate. |
| biological process |
|---|
| | GO:0050853 | | B cell receptor signaling pathway | | A series of molecular signals initiated by the cross-linking of an antigen receptor on a B cell. |
| | GO:0007186 | | G-protein coupled receptor signaling pathway | | A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576). |
| | GO:0031295 | | T cell costimulation | | The process of providing, via surface-bound receptor-ligand pairs, a second, antigen-independent, signal in addition to that provided by the T cell receptor to augment T cell activation. |
| | GO:0033277 | | abortive mitotic cell cycle | | A cell cycle in which mitosis is begun and progresses normally through the end of anaphase, but not completed, resulting in a cell with increased ploidy. |
| | GO:0006915 | | apoptotic process | | A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. |
| | GO:0030154 | | cell differentiation | | The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state. |
| | GO:0008283 | | cell proliferation | | The multiplication or reproduction of cells, resulting in the expansion of a cell population. |
| | GO:0016311 | | dephosphorylation | | The process of removing one or more phosphoric (ester or anhydride) residues from a molecule. |
| | GO:0002244 | | hematopoietic progenitor cell differentiation | | The process in which precursor cell type acquires the specialized features of a hematopoietic progenitor cell, a class of cell types including myeloid progenitor cells and lymphoid progenitor cells. |
| | GO:0035556 | | intracellular signal transduction | | The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell. |
| | GO:0050900 | | leukocyte migration | | The movement of a leukocyte within or between different tissues and organs of the body. |
| | GO:0035855 | | megakaryocyte development | | The process whose specific outcome is the progression of a megakaryocyte cell over time, from its formation to the mature structure. Megakaryocyte development does not include the steps involved in committing a cell to a megakaryocyte fate. A megakaryocyte is a giant cell 50 to 100 micron in diameter, with a greatly lobulated nucleus, found in the bone marrow. |
| | GO:0042267 | | natural killer cell mediated cytotoxicity | | The directed killing of a target cell by a natural killer cell through the release of granules containing cytotoxic mediators or through the engagement of death receptors. |
| | GO:0050859 | | negative regulation of B cell receptor signaling pathway | | Any process that stops, prevents, or reduces the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a B cell. |
| | GO:0043407 | | negative regulation of MAP kinase activity | | Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity. |
| | GO:0043409 | | negative regulation of MAPK cascade | | Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the MAPKKK cascade. |
| | GO:0042130 | | negative regulation of T cell proliferation | | Any process that stops, prevents or reduces the rate or extent of T cell proliferation. |
| | GO:0050860 | | negative regulation of T cell receptor signaling pathway | | Any process that stops, prevents, or reduces the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a T cell. |
| | GO:0008285 | | negative regulation of cell proliferation | | Any process that stops, prevents or reduces the rate or extent of cell proliferation. |
| | GO:0002924 | | negative regulation of humoral immune response mediated by circulating immunoglobulin | | Any process that stops, prevents, or reduces the frequency, rate, or extent of a humoral immune response mediated by circulating immunoglobulin. |
| | GO:0050732 | | negative regulation of peptidyl-tyrosine phosphorylation | | Any process that stops, prevents, or reduces the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine. |
| | GO:0035335 | | peptidyl-tyrosine dephosphorylation | | The removal of phosphoric residues from peptidyl-O-phospho-tyrosine to form peptidyl-tyrosine. |
| | GO:0018108 | | peptidyl-tyrosine phosphorylation | | The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine. |
| | GO:0030168 | | platelet activation | | A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug. |
| | GO:0070527 | | platelet aggregation | | The adhesion of one platelet to one or more other platelets via adhesion molecules. |
| | GO:0030220 | | platelet formation | | The process in which platelets bud from long processes extended by megakaryocytes. |
| | GO:0033630 | | positive regulation of cell adhesion mediated by integrin | | Any process that activates or increases the frequency, rate, or extent of cell adhesion mediated by integrin. |
| | GO:0008284 | | positive regulation of cell proliferation | | Any process that activates or increases the rate or extent of cell proliferation. |
| | GO:0014068 | | positive regulation of phosphatidylinositol 3-kinase signaling | | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade. |
| | GO:0006470 | | protein dephosphorylation | | The process of removing one or more phosphoric residues from a protein. |
| | GO:0045577 | | regulation of B cell differentiation | | Any process that modulates the frequency, rate or extent of B cell differentiation. |
| | GO:0070372 | | regulation of ERK1 and ERK2 cascade | | Any process that modulates the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
| | GO:2000045 | | regulation of G1/S transition of mitotic cell cycle | | Any cell cycle regulatory process that controls the commitment of a cell from G1 to S phase of the mitotic cell cycle. |
| | GO:0051279 | | regulation of release of sequestered calcium ion into cytosol | | Any process that modulates the frequency, rate or extent of the release into the cytosolic compartment of calcium ions sequestered in the endoplasmic reticulum or mitochondria. |
| | GO:0060338 | | regulation of type I interferon-mediated signaling pathway | | Any process that modulates the rate, frequency or extent of a type I interferon-mediated signaling pathway. A type I interferon-mediated signaling pathway is the series of molecular events generated as a consequence of a type I interferon binding to a cell surface receptor. |
| cellular component |
|---|
| | GO:0042105 | | alpha-beta T cell receptor complex | | A T cell receptor complex in which the TCR heterodimer comprises alpha and beta chains, associated with the CD3 complex; recognizes a complex consisting of an antigen-derived peptide bound to a class I or class II MHC protein. |
| | GO:0005911 | | cell-cell junction | | A cell junction that forms a connection between two or more cells in a multicellular organism; excludes direct cytoplasmic junctions such as ring canals. |
| | GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| | GO:0005829 | | cytosol | | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| | GO:0070062 | | extracellular exosome | | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
| | GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| | GO:0005730 | | nucleolus | | A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome. |
| | GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
Description
